Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 StudyJohn G Gerber, Susan L Rosenkranz, Carl J Fichtenbaum, et al.
Scientific Reports|July 19, 2025
Macrophage induces angiogenesis via HIF signaling in denervated muscle following nerve injuryYurie Sato-Yamada, Meircurius Dwi Condro Surboyo, Andrea L Rosenkranz, et al.
AIDS Research and Human Retroviruses|May 18, 2019
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210Victoria A Johnson, Yoninah S Cramer, Susan L Rosenkranz, et al.
Laboratory Animal Science|June 1, 1987
Epidemiology and etiology of diarrhea in colony-born Macaca nemestrinaR G Russell, S L Rosenkranz, L A Lee, et al.
British Journal of Clinical Pharmacology|October 28, 2019
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334sCharles S Venuto, Yoninah S Cramer, Susan L Rosenkranz, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 4, 2006
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherenceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
<i>Ex Vivo</i> Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult SubjectsE Wenzler, K M Meyer, S C Bleasdale, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2024
Twice-Daily Dolutegravir-Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis PreventionAnthony T Podany, Yoninah Cramer, Marjorie Imperial, et al.
Bone|June 13, 2025
The effects of Zoledronate administration routes on the reproducibility of BRONJ in rodent models: A systematic reviewMeircurius Dwi Condro Surboyo, Prasiddha Mahardhika El Fadhlallah, Yurie Sato-Yamada, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE StudyAnne F Luetkemeyer, Susan L Rosenkranz, Darlene Lu, et al.
Pageof 7